Breast Cancer Survival: Femara Better Than Tamoxifen
Older women with early breast cancers have fewer recurrences and significantly longer survival times when they take the aromatase inhibitor Femara (letrozole) instead of tamoxifen, a long-term follow-up study shows.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
